Shares of Nectar Lifesciences Ltd. gained over 18% on Thursday, December 4, after the company's board on Wednesday announced an ₹81-crore share buyback.

The record date to determine the shareholder eligibility has been fixed for December 24, 2025.

The firm will repurchase 3 crore fully paid-up equity shares at ₹27 apiece via the tender offer route, representing up to 13.38% of its paid-up equity capital. The buyback price is a premium of 51% compared to Wednesday's closing price.

The buyback size is within the 10% limit of its total paid-up capital and free reserves, based on the FY25 audited financials.

As per the company's exchange filing, the buyback will be open to all shareholders except promoters and promoter group members, who have formally expressed their intention not to p

See Full Page